Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Traynor

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Investigational New Drugs|October 12, 2013
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignanciesWilliam R Schelman, Anne M Traynor, Kyle D Holen, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2008
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignanciesSteven Attia, Sherry Morgan-Meadows, Kyle D Holen, et al.
The Lancet. Oncology|September 21, 2010
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium studyKeith C Bible, Vera J Suman, Julian R Molina, et al.
Science Translational Medicine|June 13, 2014
Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapyJamey P Weichert, Paul A Clark, Irawati K Kandela, et al.
Nature Communications|January 3, 2024
Aspergillus fumigatus mitogen-activated protein kinase MpkA is involved in gliotoxin production and self-protectionPatrícia Alves de Castro, Camila Figueiredo Pinzan, Thaila Fernanda Dos Reis, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerKeith C Bible, Vera J Suman, Michael E Menefee, et al.
Frontiers in Cellular and Infection Microbiology|October 23, 2023
Transcriptional profiling of a fungal granuloma reveals a low metabolic activity of <i>Paracoccidioides brasiliensis</i> yeasts and an actively regulated host immune responseBruno Montanari Borges, Rafael Berton Correia Ramos, Nycolas Willian Preite, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2014
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057HKeith C Bible, Vera J Suman, Julian R Molina, et al.
Research Square|July 3, 2023
Vacuoles and peroxisomes are involved in <i>Aspergillus fumigatus</i> gliotoxin production and self-protectionPatrícia Alves de Castro, Camila Figueiredo Pinzan, Thaila Fernanda Dos Reis, et al.
The Lancet. Oncology|November 14, 2017
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trialHeather A Wakelee, Suzanne E Dahlberg, Steven M Keller, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Investigational New Drugs|October 12, 2013
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignanciesWilliam R Schelman, Anne M Traynor, Kyle D Holen, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2008
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignanciesSteven Attia, Sherry Morgan-Meadows, Kyle D Holen, et al.
The Lancet. Oncology|September 21, 2010
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium studyKeith C Bible, Vera J Suman, Julian R Molina, et al.
Science Translational Medicine|June 13, 2014
Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapyJamey P Weichert, Paul A Clark, Irawati K Kandela, et al.
Nature Communications|January 3, 2024
Aspergillus fumigatus mitogen-activated protein kinase MpkA is involved in gliotoxin production and self-protectionPatrícia Alves de Castro, Camila Figueiredo Pinzan, Thaila Fernanda Dos Reis, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerKeith C Bible, Vera J Suman, Michael E Menefee, et al.
Frontiers in Cellular and Infection Microbiology|October 23, 2023
Transcriptional profiling of a fungal granuloma reveals a low metabolic activity of <i>Paracoccidioides brasiliensis</i> yeasts and an actively regulated host immune responseBruno Montanari Borges, Rafael Berton Correia Ramos, Nycolas Willian Preite, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2014
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057HKeith C Bible, Vera J Suman, Julian R Molina, et al.
Research Square|July 3, 2023
Vacuoles and peroxisomes are involved in <i>Aspergillus fumigatus</i> gliotoxin production and self-protectionPatrícia Alves de Castro, Camila Figueiredo Pinzan, Thaila Fernanda Dos Reis, et al.
The Lancet. Oncology|November 14, 2017
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trialHeather A Wakelee, Suzanne E Dahlberg, Steven M Keller, et al.
Pageof 17